Literature DB >> 20428111

Targeting microRNAs with small molecules: from dream to reality.

S Zhang1, L Chen, E J Jung, G A Calin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20428111      PMCID： PMC3902962          DOI： 10.1038/clpt.2010.46

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  28 in total

1.  Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock.

Authors:  Fredrik Osterberg; Garrett M Morris; Michel F Sanner; Arthur J Olson; David S Goodsell
Journal:  Proteins       Date:  2002-01-01

2.  Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.

Authors:  Kenneth E Lind; Zhihua Du; Koh Fujinaga; B Matija Peterlin; Thomas L James
Journal:  Chem Biol       Date:  2002-02

3.  Validation of automated docking programs for docking and database screening against RNA drug targets.

Authors:  Carsten Detering; Gabriele Varani
Journal:  J Med Chem       Date:  2004-08-12       Impact factor: 7.446

4.  Docking of aminoglycosides to hydrated and flexible RNA.

Authors:  Nicolas Moitessier; Eric Westhof; Stephen Hanessian
Journal:  J Med Chem       Date:  2006-02-09       Impact factor: 7.446

5.  Small-molecule inhibitors of microrna miR-21 function.

Authors:  Kiranmai Gumireddy; Douglas D Young; Xin Xiong; John B Hogenesch; Qihong Huang; Alexander Deiters
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

6.  The evolution of our thinking about microRNAs.

Authors:  Victor Ambros
Journal:  Nat Med       Date:  2008-10       Impact factor: 53.440

Review 7.  RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment.

Authors:  Riccardo Spizzo; David Rushworth; Manrique Guerrero; George A Calin
Journal:  Clin Lymphoma Myeloma       Date:  2009

8.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.

Authors:  Ulf Klein; Marie Lia; Marta Crespo; Rachael Siegel; Qiong Shen; Tongwei Mo; Alberto Ambesi-Impiombato; Andrea Califano; Anna Migliazza; Govind Bhagat; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2010-01-07       Impact factor: 31.743

Review 9.  Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes.

Authors:  George A Calin; Carlo M Croce
Journal:  Blood       Date:  2009-09-10       Impact factor: 22.113

10.  Structural insights into RNA processing by the human RISC-loading complex.

Authors:  Hong-Wei Wang; Cameron Noland; Bunpote Siridechadilok; David W Taylor; Enbo Ma; Karin Felderer; Jennifer A Doudna; Eva Nogales
Journal:  Nat Struct Mol Biol       Date:  2009-10-11       Impact factor: 15.369
View more
  44 in total

Review 1.  Genome-wide approaches in the study of microRNA biology.

Authors:  Melissa L Wilbert; Gene W Yeo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

Review 2.  Missing link between microRNA and prostate cancer.

Authors:  Balraj Singh Gill; Jimi Marin Alex; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2016-01-28

3.  Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease.

Authors:  Fanlin Meng; Enyu Dai; Xuexin Yu; Yan Zhang; Xiaowen Chen; Xinyi Liu; Shuyuan Wang; Lihua Wang; Wei Jiang
Journal:  J R Soc Interface       Date:  2013-12-18       Impact factor: 4.118

Review 4.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development.

Authors:  Hui Ling; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

Review 5.  Targeting microRNAs in pancreatic cancer: microplayers in the big game.

Authors:  Sheema Khan; Deepak Kumar; Meena Jaggi; Subhash C Chauhan
Journal:  Cancer Res       Date:  2013-11-07       Impact factor: 12.701

6.  MicroRNA-21 in scleroderma fibrosis and its function in TGF-β-regulated fibrosis-related genes expression.

Authors:  Honglin Zhu; Hui Luo; Yisha Li; Yaou Zhou; Ying Jiang; Jin Chai; Xianzhong Xiao; Yunhui You; Xiaoxia Zuo
Journal:  J Clin Immunol       Date:  2013-05-09       Impact factor: 8.317

Review 7.  Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics.

Authors:  Rengen Fan; Chaocheng Xiao; Xinqiang Wan; Wenzhang Cha; Yufeng Miao; Yong Zhou; Chenglin Qin; Ting Cui; Fenglian Su; Xiangxiang Shan
Journal:  RNA Biol       Date:  2019-04-03       Impact factor: 4.652

8.  Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors.

Authors:  Rasmus O Bak; Anne Kruse Hollensen; Maria Nascimento Primo; Camilla Darum Sørensen; Jacob Giehm Mikkelsen
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

Review 9.  Long noncoding RNAs: fresh perspectives into the RNA world.

Authors:  Lin Yang; John E Froberg; Jeannie T Lee
Journal:  Trends Biochem Sci       Date:  2013-11-27       Impact factor: 13.807

10.  Exploring the associations between microRNA expression profiles and environmental pollutants in human placenta from the National Children's Study (NCS).

Authors:  Qian Li; Maya A Kappil; An Li; Priyanthi S Dassanayake; Thomas H Darrah; Alan E Friedman; Michelle Friedman; Luca Lambertini; Philip Landrigan; Christopher J Stodgell; Yulin Xia; Jessica A Nanes; Kjersti M Aagaard; Eric E Schadt; Jeff C Murray; Edward B Clark; Nancy Dole; Jennifer Culhane; James Swanson; Michael Varner; Jack Moye; Carol Kasten; Richard K Miller; Jia Chen
Journal:  Epigenetics       Date:  2015-08-07       Impact factor: 4.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.